20/20 OptimEyes Technologies
Proprietary micelle-based ocular drug-delivery platform that controls release and prolongs drug penetration into the eye.
Treats glaucoma and dry eye disease with comfortable eye drops usable once or twice weekly to improve dosing convenience and patient compliance.
Employees
loading...
Funding Status
loading...
Established
loading...
Total Funding
loading...
ARR
loading...
Insights
Loading Insights...
Loading Insight content to display...
Loading Insights...
Loading Insight content to display...
Founders
loading...
Notable Customers
loading...
Funding
Workforce
Functional Distribution
N/A
Open Positions
N/A
Diversity
N/A